世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

前立腺癌治療薬の世界市場に関する洞察と2028年までの予測


Global Prostate Cancer Therapeutics Drugs Market Insights and Forecast to 2028

市場の分析と洞察。前立腺癌治療薬の世界市場 COVID-19の流行により、前立腺癌治療薬の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになる... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年2月18日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。前立腺癌治療薬の世界市場
COVID-19の流行により、前立腺癌治療薬の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に前立腺癌治療薬の世界市場の%を占めたホルモン療法は、2028年までに百万米ドルの価値を持ち、COVID-19以降の期間に修正された%のCAGRで成長すると予測されます。一方、病院薬局セグメントは、この予測期間を通して%CAGRに変更されています。

中国の前立腺癌治療薬の市場規模は2021年に100万米ドル、米国と欧州の前立腺癌治療薬はそれぞれ100万米ドル、100万米ドルと評価されています。2021年の米国の割合は%、中国と欧州はそれぞれ%、%で、中国の割合は2028年には%に達すると予測され、分析期間を通じてCAGRは%を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの前立腺癌治療薬の展望については、ドイツは2028年までに100万米ドルに達し、予測期間中にCAGR %を推移すると予測されています。
前立腺癌治療薬の世界の主要メーカーは、ジョンソン・エンド・ジョンソン、ファイザー、アストラゼネカ、アムジェン、アッヴィ、バイエル、イプセン、サノフィ、遠藤製薬などです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の前立腺癌治療薬の範囲とセグメント
前立腺癌治療薬市場は、タイプ別、販売チャネル別に区分される。世界の前立腺癌治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年までのタイプ別および販売チャネル別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
ホルモン療法
化学療法
生物学的療法
標的療法
その他
販売チャネル別セグメント
病院薬局
小売店
オンライン販売
その他

会社別
ジョンソン・エンド・ジョンソン
ファイザー株式会社
アストラゼネカ
アムジェン社
アッヴィ(AbbVie, Inc
バイエルAG
イプセン グループ
サノフィ
遠藤製薬
デンドレオン株式会社

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Prostate Cancer Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Market by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prostate Cancer Therapeutics Drugs Sales by Region
2.4.1 Global Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Prostate Cancer Therapeutics Drugs by Region (2023-2028)
2.5 Global Prostate Cancer Therapeutics Drugs Revenue by Region
2.5.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Prostate Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Therapeutics Drugs in 2021
3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Drugs Revenue in 2021
3.3 Global Prostate Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prostate Cancer Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type
4.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type
4.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type
4.3.1 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel
5.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Sale Channel (2017-2022)
5.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Sale Channel (2023-2028)
5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2028)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel
5.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Sale Channel (2017-2022)
5.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Sale Channel (2023-2028)
5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2028)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel
5.3.1 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022)
5.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Prostate Cancer Therapeutics Drugs Market Size by Type
6.1.1 North America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
6.2.1 North America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
6.2.2 North America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
6.3 North America Prostate Cancer Therapeutics Drugs Market Size by Country
6.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Type
7.1.1 Europe Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
7.2.1 Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
7.2.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
7.3 Europe Prostate Cancer Therapeutics Drugs Market Size by Country
7.3.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
8.2.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
8.2.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
8.3 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Type
9.1.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
9.2.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
9.2.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
9.3 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country
9.3.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
10.2.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
10.2.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
10.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Overview
11.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer, Inc Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Amgen, Inc
11.4.1 Amgen, Inc Corporation Information
11.4.2 Amgen, Inc Overview
11.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen, Inc Recent Developments
11.5 AbbVie, Inc
11.5.1 AbbVie, Inc Corporation Information
11.5.2 AbbVie, Inc Overview
11.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie, Inc Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Corporation Information
11.6.2 Bayer AG Overview
11.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer AG Recent Developments
11.7 Ipsen Group
11.7.1 Ipsen Group Corporation Information
11.7.2 Ipsen Group Overview
11.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ipsen Group Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Corporation Information
11.9.2 Endo Pharmaceuticals Overview
11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Endo Pharmaceuticals Recent Developments
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Corporation Information
11.10.2 Dendreon Corporation Overview
11.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dendreon Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis
12.2 Prostate Cancer Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Therapeutics Drugs Production Mode & Process
12.4 Prostate Cancer Therapeutics Drugs Sales and Marketing
12.4.1 Prostate Cancer Therapeutics Drugs Sales Channels
12.4.2 Prostate Cancer Therapeutics Drugs Distributors
12.5 Prostate Cancer Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prostate Cancer Therapeutics Drugs Industry Trends
13.2 Prostate Cancer Therapeutics Drugs Market Drivers
13.3 Prostate Cancer Therapeutics Drugs Market Challenges
13.4 Prostate Cancer Therapeutics Drugs Market Restraints
14 Key Findings in The Global Prostate Cancer Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Prostate Cancer Therapeutics Drugs Market
Due to the COVID-19 pandemic, the global Prostate Cancer Therapeutics Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hormone Therapy accounting for % of the Prostate Cancer Therapeutics Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.

China Prostate Cancer Therapeutics Drugs market size is valued at US$ million in 2021, while the US and Europe Prostate Cancer Therapeutics Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prostate Cancer Therapeutics Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Prostate Cancer Therapeutics Drugs include Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi and Endo Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Prostate Cancer Therapeutics Drugs Scope and Segment
Prostate Cancer Therapeutics Drugs market is segmented by Type and by Sale Channel. Players, stakeholders, and other participants in the global Prostate Cancer Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sale Channel for the period 2017-2028.

Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Other
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other

By Company
Johnson & Johnson
Pfizer, Inc
AstraZeneca
Amgen, Inc
AbbVie, Inc
Bayer AG
Ipsen Group
Sanofi
Endo Pharmaceuticals
Dendreon Corporation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Prostate Cancer Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Market by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prostate Cancer Therapeutics Drugs Sales by Region
2.4.1 Global Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Prostate Cancer Therapeutics Drugs by Region (2023-2028)
2.5 Global Prostate Cancer Therapeutics Drugs Revenue by Region
2.5.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Prostate Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Therapeutics Drugs in 2021
3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Drugs Revenue in 2021
3.3 Global Prostate Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prostate Cancer Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type
4.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type
4.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type
4.3.1 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel
5.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Sale Channel (2017-2022)
5.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Sale Channel (2023-2028)
5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2028)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel
5.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Sale Channel (2017-2022)
5.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Sale Channel (2023-2028)
5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2028)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel
5.3.1 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022)
5.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Prostate Cancer Therapeutics Drugs Market Size by Type
6.1.1 North America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
6.2.1 North America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
6.2.2 North America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
6.3 North America Prostate Cancer Therapeutics Drugs Market Size by Country
6.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Type
7.1.1 Europe Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
7.2.1 Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
7.2.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
7.3 Europe Prostate Cancer Therapeutics Drugs Market Size by Country
7.3.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
8.2.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
8.2.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
8.3 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Type
9.1.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
9.2.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
9.2.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
9.3 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country
9.3.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Sale Channel
10.2.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028)
10.2.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028)
10.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Overview
11.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer, Inc Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Amgen, Inc
11.4.1 Amgen, Inc Corporation Information
11.4.2 Amgen, Inc Overview
11.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen, Inc Recent Developments
11.5 AbbVie, Inc
11.5.1 AbbVie, Inc Corporation Information
11.5.2 AbbVie, Inc Overview
11.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie, Inc Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Corporation Information
11.6.2 Bayer AG Overview
11.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer AG Recent Developments
11.7 Ipsen Group
11.7.1 Ipsen Group Corporation Information
11.7.2 Ipsen Group Overview
11.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ipsen Group Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Corporation Information
11.9.2 Endo Pharmaceuticals Overview
11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Endo Pharmaceuticals Recent Developments
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Corporation Information
11.10.2 Dendreon Corporation Overview
11.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dendreon Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis
12.2 Prostate Cancer Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Therapeutics Drugs Production Mode & Process
12.4 Prostate Cancer Therapeutics Drugs Sales and Marketing
12.4.1 Prostate Cancer Therapeutics Drugs Sales Channels
12.4.2 Prostate Cancer Therapeutics Drugs Distributors
12.5 Prostate Cancer Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prostate Cancer Therapeutics Drugs Industry Trends
13.2 Prostate Cancer Therapeutics Drugs Market Drivers
13.3 Prostate Cancer Therapeutics Drugs Market Challenges
13.4 Prostate Cancer Therapeutics Drugs Market Restraints
14 Key Findings in The Global Prostate Cancer Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/05 10:26

153.43 円

167.28 円

201.52 円

ページTOPに戻る